Bacterin International, Inc. Announces The Launch Of OsteoSTX, A Novel Biologic Product
3/13/2014 8:15:02 AM
BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE) is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin’s proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Help employers find you! Check out all the jobs and post your resume.
comments powered by